The diagnostics of the superficialtransitional cell bladder carcinoma

封面


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The literature review is devoted to current methods of transitional cell urinary bladder cancer diagnosis and is based on European association of urology guidelines. Perspectives of the future development of diagnostic tests aimed towards higher sensitivity and specificity in early stages of bladder cancer development are shown.

全文:

受限制的访问

作者简介

Salman Al-Shukri

First St.-Petersburg State I. P. Pavlov Medical University

Email: al- shukri@mail.ru
doctor of medical science, professor, head of the department. Department of Urology

Igor Korneyev

First St.-Petersburg State I. P. Pavlov Medical University

Email: iakorneyev@yandex.ru
doctor of medical science, professor

参考

  1. Аль-Шукри С. Х., Ткачук В. Н. Опухоли мочеполовых органов.СПб: Питер, 2000. С. 309.
  2. Корнеев И. А. Прогнозирование клинического течения поверхностного и местно-распространенного рака уротелия: Автореф. дис. д-ра мед. наук: 14.00.40 / С-Петербургский гос. мед. ун-т им. акад. И. П. Павлова. С-Пб., 2006. С. 34.
  3. Palou J., Rodriguez-Rubio F., Huguet J. et al. Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumours // J. Urol. 2005. Vol.174 (3). P. 859–861.
  4. Nolte-Ernsting C., Cowan N. Understanding multislice CT urography techniques: many roads lead to Rome // Eur. Radiol. 2006. Vol.16 (12). P. 2670–2686.
  5. Goessl C., Knispel H. H., Millar K. et al. Is routine excretory urography necessary at first diagnosis of bladder cancer? // J. Urol. 1997. Vol.157 (2). P. 480–481.
  6. Têtu B. Diagnosis of urothelial carcinoma from urine // Mod Pathol. 2009. Vol. 22 (Suppl 2). S. 53–59.
  7. Yutkin V., Nisman B., Pode D. Can urinary biomarkers replace cystoscopic examination in bladder cancer surveillance? // Expert Rev Anticancer. 2010. Vol. 10 (6). P. 787–790.
  8. Schlomer B. J., Ho R., Sagalowsky A. et al. Prospective Validation of the Clinical Usefulness of Reflex Fluorescence In Situ Hybridization Assay in Patients With Atypical Cytology for the Detection of Urothelial Carcinoma of the Bladder // J. Urol. 2010. Vol. 183 (1). P. 62–67.
  9. Aaronson D. S., Walsh T. J., Smith J. F. et al. Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? // BJU Int. 2009. Vol. 104 (4). P. 506–509; discussion 509–10.
  10. Blick C. G., Nazir S. A., Mallett S. et al. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic // BJU Int. 2012. Vol. 110 (1). P. 84–94.
  11. Mungan M. U., Canda A. E., Tuzel E. et al. Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder // Eur. Urol. 2005. Vol. 48 (5). P. 760–763.
  12. Grossman H. B., Stenzl A., Fradet Y. et al. Long-term decrease in bladder cancer recurrence with examinolevulinate enabled fluorescence cystoscopy // J. Urol. 2012. Vol. 188 (1). P. 58–62.
  13. Cauberg E. C., Kloen S., Visser M. et al. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer // Urology. 2010. Vol. 76 (3). P. 658–663.
  14. Данильченко Д. И., Кениг Ф., Кастайн А. и др. Интравитальная оптическая биопсия рака мочевого пузыря: реальность и перспективы развития. Тезисы докладов четвертого международного урологического симпозиума «Диагностика и лечение рака мочевого пузыря», Нижний Новгород, 2005. С. 24.
  15. Divrik R. T., Yildirim Ü., Zorlu F. et al. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumours of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial // J. Urol. 2006. Vol. 175 (5). P. 1641–1644.
  16. Lopez-Beltran A., Bassi P., Pavone-Macaluso M. et al. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis // Eur. Urol. 2004. Vol.45 (3). P. 257–266.
  17. Sylvester R. J., van der Meijden A. P., Oosterlinck W. et al. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials // Eur. Urol. 2006. Vol. 49 (3). P. 466–465.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Al-Shukri S.H., Korneyev I.A., 2013

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 89281 от 21.04.2025.